Tirzepatide Cuts BMI in Adolescents With Obesity in Phase III Trial

Summary
(MedPage Today) -- NATIONAL HARBOR, Md. -- Tirzepatide (Zepbound) yielded substantial reductions in BMI among adolescents with obesity or overweight with obesity-related complications, the phase III SURMOUNT-ADOLESCENTS trial showed. At week...
Description from Medpagetoday.
Who is covering this
-
Tirzepatide Cuts BMI in Adolescents With Obesity in Phase III Trial
(MedPage Today) -- NATIONAL HARBOR, Md. -- Tirzepatide (Zepbound) yielded substantial reductions in BMI among adolescents with obesity or overweight with obesity-related complications, the phase III SURMOUNT-ADOLESCENTS trial showed. At week...
Comments
Comments need JavaScript.